XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ 28,884 $ (10,942)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 121,184 109,386
Equity in income of joint ventures (12,955) (7,736)
Stock-based compensation expense 19,251 14,682
Elimination of unrealized (loss) gain on sales to joint ventures (312) 3,520
Changes in fair value of contingent consideration (5,761) 0
Deferred taxes (1,126) (8,066)
Unrealized foreign exchange losses 3,418 1,725
Changes in assets and liabilities:    
Accounts receivable, net (28,676) 3,193
Inventories (15,367) (587)
Other assets (11,471) (15,279)
Accounts payable and accrued liabilities (19,617) 29,269
Other liabilities (8,463) (15,422)
Income taxes, net 3,375 4,481
Dividends received from joint ventures 4,132 2,754
Other (4,418) (5,450)
Net cash provided by operating activities 72,078 105,528
Cash flows from investing activities:    
Capital expenditures (99,158) (84,623)
Payment for acquisition of business, net of cash acquired (31,967) (8,477)
Proceeds from settlement of contingent consideration 7,500 0
Proceeds from disposal of assets 2,900 2,013
Proceeds from sale / maturity of investments 0 288
Net cash used in investing activities (120,725) (90,799)
Cash flows from financing activities:    
Release of collateral deposits, net 1,242 350
Proceeds from borrowings 117,269 50,000
Repayment of borrowings (44,351) 0
Repurchase of common stock 0 (10,011)
Payment of withholding taxes on stock-based compensation plans (3,269) (2,436)
Repayment of financed insurance premium (7,828) (6,733)
Repayments of finance leases (1,055) (1,296)
Net cash provided by financing activities 62,008 29,874
Effect of exchange rate changes on cash and cash equivalents 458 (6,052)
Net increase to cash and cash equivalents and restricted cash 13,819 38,551
Cash and cash equivalents and restricted cash at beginning of period 153,166 218,460
Cash and cash equivalents and restricted cash at end of period $ 166,985 $ 257,011